Description
Revision is a research peptide blend (5 mL) combining LL-37, TB-500, Thymosin Alpha-1, BPC-157, dosed at 5/10/10/10 mg in the listed order. Component research areas: Antimicrobial/wound healing; tissue repair/anti-inflammatory; immune modulation; tissue repair. See each individual compound page for full detail. For research use only; not FDA-approved.
